Structured evidence table for Phytosterols Cholesterol Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Phytosterols Cholesterol Meta-Analysis | Consequently, healthcare initiatives worldwide are placing greater emphasis on preventing and lowering cerebrovascular risk. | 4 | Pacinella G (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health-Narrative Review. |
| Phytosterols Cholesterol Meta-Analysis | Alongside medical therapies, it is now widely recognized that modifying risk factors-many of which are controllable-can substantially reduce the probability of acute cerebrovascular events, up to 33% according to data from trials such as PREDIMED. | 4 | Pacinella G (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health-Narrative Review. |
| Phytosterols Cholesterol Meta-Analysis | The MedDiet, long established as the traditional eating pattern in Mediterranean regions, is an effective means of counteracting factors that jeopardize vascular health and elevate the risk of acute events. | 4 | Pacinella G (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health-Narrative Review. |
| Phytosterols Cholesterol Meta-Analysis | Ischemic stroke and its chronic cerebrovascular complications represent significant public health challenges with considerable societal impact. | 4 | Pacinella G (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health-Narrative Review. |
| Phytosterols Cholesterol Meta-Analysis | Two key issues remain: despite extensive research, the etiology of premature atherosclerosis in sitosterolemia is still uncertain, and discussion of phytosterol atherogenicity has not been grounded in quantitative evidence, hindering true risk assessment. | 4 | Nakano T (2025) | Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols. |
| Phytosterols Cholesterol Meta-Analysis | Although ABCG5/G8-deficient animal models recapitulate the symptoms of sitosterolemia, including hematologic abnormalities and organ dysfunction, increased atherogenicity has not been observed in these models. | 4 | Nakano T (2025) | Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols. |
| Phytosterols Cholesterol Meta-Analysis | Mendelian randomization studies have indicated an association between circulating phytosterol levels and ASCVD risk; however, genetic background, sterol absorption efficiency, and metabolic disturbances modulate these levels, potentially confounding the interpretation of such associations. | 4 | Nakano T (2025) | Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols. |
| Phytosterols Cholesterol Meta-Analysis | Purpose of review Dysfunction of the ATP-binding cassette G5/G8 heterodimier (ABCG5/G8) leads to sitosterolemia, a condition in which premature atherosclerosis is often observed, thereby linking elevated circulating phytosterols to atherogenicity. | 4 | Nakano T (2025) | Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols. |
Source documents